HNRNPA1 and breast cancer: For example, overexpression of hnRNPA1 has been reported from gliomas, lymphomas, myelomas, leukemias, and breast, colorectal, gastric, and lung cancers [2, 4, 7, 16, 38, 44, 47], and was linked to poor prognosis in hepatocellular carcinoma [50] and breast cancer [37].